Pixelgen Technologies develops technologies for biomedical research and diagnostics.
Pixelgen Technologies has raised $15.5M in total funding. The most recent round was Series B. The last funding was announced in August 2026.
Pixelgen Technologies's investors include Flat Capital, EIC Accelerator, Industrifonden, Navigare Ventures, Colibri Ventures.
Pixelgen Technologies is headquartered in Stockholm, Sweden.
Pixelgen Technologies develops technologies for biomedical research and diagnostics.
Pixelgen Technologies is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pixelgen Technologies — Funding & Investors." VCBacked, August 20, 2026, https://www.vcbacked.co/company/pixelgen-technologies. Accessed September 2, 2026.
VCBacked. (2026). Pixelgen Technologies — Funding & Investors. Retrieved September 2, 2026, from https://www.vcbacked.co/company/pixelgen-technologies
{{cite web |title=Pixelgen Technologies — Funding & Investors |url=https://www.vcbacked.co/company/pixelgen-technologies |website=VCBacked |access-date=September 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated